RSV IMMUNIZATION

Clinical trials for RSV IMMUNIZATION explained in plain language.

Never miss a new study

Get alerted when new RSV IMMUNIZATION trials appear

Sign up with your email to follow new studies for RSV IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1 Terminated 1

One-dose antibody slashes RSV hospitalizations in infants

Prevention Completed

This study tested a single injection of nirsevimab in over 8,000 healthy infants under 1 year old to see if it could prevent hospitalizations from RSV, a common respiratory virus. Babies received either the shot or no intervention and were followed for up to 6 months. The goal wa…

Matched conditions: RSV IMMUNIZATION

Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention

Last updated Jun 27, 2026 07:54 UTC

RSV IMMUNIZATION

Get alerted when new RSV IMMUNIZATION trials appear

One-dose antibody slashes RSV hospitalizations in infants